Nephrology Grand Rounds: Sglt2 Inhibitors

Nephrology Grand Rounds: SGLT2 Inhibitors

Ottawa Nephrology

"SGLT2 Inhibitors: Mechanisms of Behind the Mortality Benefit" presented by Amy Li

University of Colorado | Department of Medicine

SGLT2 Inhibitor Interdisciplinary Forum

University of Washington Division of Nephrology

Christine Limonte, MD - Update on SGLT2i: Real-world Use and Special Population

University of Washington Division of Nephrology

Iris De Castro, MD - SGLT2 inhibitor in Kidney Transplantation: Is it ready for prime time?

University of Washington Division of Nephrology

Nephrology Grand Rounds - April 28, 2022

Department of Medicine

How SGLT2 Inhibitors Protect The Kidney

Conan Liu, M.D.

Medicine Grand Rounds: "Updates in Nephrology" 4/13/21

Emory Department of Medicine

Medical Grand Rounds, October 14, 2021

McMaster University - Department of Medicine

Nephrology Grand Rounds - April 13, 2023

Department of Medicine

SGLT2 Inhibitors in Chronic Kidney Disease

Harvard Medical School Continuing Education

A Cardiologist, Nephrologist, and Endocrinologist Walk Into a Bar…

Yale Cardiovascular Medicine Grand Rounds

11-10-2022 - SGLT2i: Evidence and Mechanisms for a Nephrology-Cardiology Consensus

WashU Medicine Department of Medicine

UofL Medicine Grand Rounds: Dr. Vanita Aroda

Grand Rounds October 1st 2020 - Evolving Therapies in Diabetes, Heart Failure and Renal Impairment

Dundee University and NHS Tayside Grand Rounds

Grand Rounds: Chronic Kidney Disease Update

Part 6 - Primary Care Insights from the KDIGO CKD Guideline: SGLT2 Inhibitors

CWMGR: The Expanding Multiverse of SGLTi In & Beyond Diabetes

Department of Medicine — University of Toronto

SGLT2 Inhibitors: Can these drugs slow the progression of chronic kidney disease?